These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28944430)

  • 41. Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis.
    Liu D; Guo H; Li Y; Xu X; Yang K; Bai Y
    PLoS One; 2012; 7(2):e31251. PubMed ID: 22348060
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis.
    Dörr S; Lechtenböhmer N; Rau R; Herborn G; Wagner U; Müller-Myhsok B; Hansmann I; Keyszer G
    Arthritis Res Ther; 2004; 6(3):R199-207. PubMed ID: 15142265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Meta-analysis of associations between four polymorphisms in the matrix metalloproteinases gene and gastric cancer risk.
    Yang TF; Guo L; Wang Q
    Asian Pac J Cancer Prev; 2014; 15(3):1263-7. PubMed ID: 24606450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Matrix metalloprotease polymorphisms are associated with gas transfer in alpha 1 antitrypsin deficiency.
    McAloon CJ; Wood AM; Gough SC; Stockley RA
    Ther Adv Respir Dis; 2009 Feb; 3(1):23-30. PubMed ID: 19293200
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Variation of matrix metalloproteinase 1 and 3 haplotypes and their serum levels in patients with rheumatoid arthritis and osteoarthritis.
    Abd-Allah SH; Shalaby SM; Pasha HF; El-Shal AS; Abou El-Saoud AM
    Genet Test Mol Biomarkers; 2012 Jan; 16(1):15-20. PubMed ID: 21770773
    [TBL] [Abstract][Full Text] [Related]  

  • 46. rs3918242 MMP9 gene polymorphism is associated with myocardial infarction in Mexican patients.
    Rodríguez-Pérez JM; Vargas-Alarcón G; Posadas-Sánchez R; Zagal-Jiménez TX; Ortíz-Alarcón R; Valente-Acosta B; Tovilla-Zárate C; Nostroza-Hernández C; Pérez-Méndez O; Pérez-Hernández N
    Genet Mol Res; 2016 Mar; 15(1):15017776. PubMed ID: 26985929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Association of matrix metalloproteinases' polymorphisms of MMP3 and MMP9 with development of genital endometriosis].
    Iarmolinskaia MI; Molotkov AS; Bezhenar' VF; Shved NIu; Ivashchenko TE; Baranov VS
    Genetika; 2014 Feb; 50(2):230-5. PubMed ID: 25711032
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association study for the role of Matrix metalloproteinases 2 and 3 gene polymorphisms in dental caries susceptibility.
    Karayasheva D; Glushkova M; Boteva E; Mitev V; Kadiyska T
    Arch Oral Biol; 2016 Aug; 68():9-12. PubMed ID: 27043485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Age at onset of rheumatoid arthritis: association with polymorphisms in the vascular endothelial growth factor A(VEGFA) gene and an intergenic locus between matrix metalloproteinase (MMP) 1 and 3 genes.
    Chen Y; Mattey DL
    Clin Exp Rheumatol; 2012; 30(6):894-8. PubMed ID: 22776467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Contribution of Matrix Metalloproteinase-7 Promoter Genotypes in Breast Cancer in Taiwan.
    Chou AK; Hsiao CL; Shih TC; Wang HC; Tsai CW; Chang WS; Liu LC; Way TD; Chung JG; Bau DT
    Anticancer Res; 2017 Sep; 37(9):4973-4977. PubMed ID: 28870920
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Matrix metalloproteinase 3 polymorphisms as a potential marker of enhanced susceptibility to lung cancer in chronic obstructive pulmonary disease subjects.
    Brzóska K; Bartłomiejczyk T; Sochanowicz B; Cymerman M; Grudny J; Kołakowski J; Kapka-Skrzypczak L; Kruszewski M; Sliwiński P; Roszkowski-Śliż K
    Ann Agric Environ Med; 2014; 21(3):546-51. PubMed ID: 25292126
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma.
    Kondo S; Wakisaka N; Schell MJ; Horikawa T; Sheen TS; Sato H; Furukawa M; Pagano JS; Yoshizaki T
    Int J Cancer; 2005 Jun; 115(3):368-76. PubMed ID: 15688379
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polymorphic Variants rs13155212 (T/C) and rs7704267 (G/C) in the AGGF1 Gene and Risk of Varicose Veins of the Lower Extremities in the Population of Ethnic Russians.
    Shadrina AS; Smetanina MA; Sevost'ianova KS; Sokolova EA; Shevela AI; Selivestrov EI; Demekhova MY; Shonov OA; Ilyukhin EA; Voronina EN; Zolotukhin IA; Kirienko AI; Filipenko ML
    Bull Exp Biol Med; 2016 Sep; 161(5):698-702. PubMed ID: 27704351
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Matrix metalloproteinase-7 (MMP-7) polymorphism is a risk factor for endometrial cancer susceptibility.
    Yi YC; Chou PT; Chen LY; Kuo WH; Ho ES; Han CP; Yang SF
    Clin Chem Lab Med; 2010 Mar; 48(3):337-44. PubMed ID: 20113256
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility.
    Wieczorek E; Reszka E; Jablonowski Z; Jablonska E; Krol MB; Grzegorczyk A; Gromadzinska J; Sosnowski M; Wasowicz W
    BJU Int; 2013 Dec; 112(8):1207-14. PubMed ID: 23819551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population.
    Mirowska-Guzel D; Gromadzka G; Czlonkowski A; Czlonkowska A
    J Neuroimmunol; 2009 Sep; 214(1-2):113-7. PubMed ID: 19628284
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India.
    Srivastava P; Kapoor R; Mittal RD
    Urol Oncol; 2013 Feb; 31(2):247-54. PubMed ID: 21784671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
    Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polymorphisms in MMP-9 and TIMP-2 in Chinese patients with varicose veins.
    Xu HM; Zhao Y; Zhang XM; Zhu T; Fu WG
    J Surg Res; 2011 Jun; 168(1):e143-8. PubMed ID: 21195432
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.
    Peng B; Cao L; Ma X; Wang W; Wang D; Yu L
    Mutagenesis; 2010 Jul; 25(4):371-9. PubMed ID: 20360147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.